The EMJ Podcast | Episode 231
In this episode, Jonathan Sackier welcomes Martin Whyte to delve into the intricate world of metabolic medicine. Together, they discuss groundbreaking research on diabetes, non-alcoholic fatty liver disease, and polycystic ovarian syndrome, as well as how metabolic research is shaping the future of preventative care and treatment.
Spotify | Apple | Amazon Music | Youtube | Download MP3 (42:57 mins)
Martin Whyte is an Associate Professor of Nutrition and Metabolism at the University of Surrey and a Consultant in Diabetes at King’s College Hospital, London, UK. He earned his medical degree from King’s College London and completed a PhD at Guy’s & St. Thomas’ Hospital, investigating the metabolic effects of insulin during critical illness.
Since 2012, Whyte has balanced NHS consulting with academia. With over 100 publications, his expertise spans diabetes, fatty liver disease, and fertility disorders like PCOS. His current research focuses on bridging metabolic medicine with preventative care, aiming to improve global health outcomes. He also serves as Editor-in-Chief of the EMJ Diabetes editorial board.
- 00:00 – Introduction
- 02:10 – Journey into metabolic medicine
- 03:23 – Advances in Diabetes science
- 06:22 – Obesity and economic impact
- 08:28 – Patient terminology discussion
- 14:55 – Metabolic and chronic conditions
- 19:21 – Fatty liver disease
- 25:36 – Preventative health strategies
- 29:51 – Future of metabolic research
- 33:13 – Impact of GLP-1 drugs
- 37:08 – Fertility and menstrual disorders
- 41:01 – Three wishes for healthcare
